BrainsWay Inks Distribution Agreement to Expand Foothold

Quick Summary:

BrainsWay Ltd.(NASDAQ: BWAY) recently signed an exclusive multi-year distribution agreement with a specialty distributor serving both the acute hospital and non-acute healthcare spaces in Canada.

BrainsWay's unique therapeutic solution, Deep TMS, is currently cleared in Canada to treat major depressive disorder and obsessive-compulsive disorder (OCD).

One in two Canadians have, or have had, a mental illness by the time they reach 40 years of age and only half of Canadians experiencing a major depressive episode receive potentially adequate care.Management ...

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Zacks

Category: Technology

Markets: United StatesCanadaIsrael

Topics: News General Analyst Ratings Trading Ideas Health Care Contributors BWAY DVA BSX ECL Tech Earnings Markets

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-06-19 @ 17:38:10 (1 weeks ago)

News Timezone: GMT +8:00

News Source URL: benzinga.com

Language: English

Article Length: 741 words

Reading Time: 5 minutes read

Sentences: 36 lines

Sentence Length: 21 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Benzinga

News ID: 21314869

View Article Analysis

About Benzinga

Main Topics: Technology

Official Website: benzinga.com

Update Frequency: 8 posts per day

Year Established: 2010

Headquarters: United States

News Last Updated: 20 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #53

Publisher Details

Frequently Asked Questions